August 30, 2009New England Journal of Medicine
Ticagrelor — Is There Need for a New Player in the Antiplatelet-Therapy Field?
Design
Editorial
Authors
Discussion
Loading...
Member takes
Implication
Discusses the limitations of clopidogrel, including delayed onset, variability in response, and irreversibility, highlighting the potential need for new antiplatelet agents like ticagrelor.
Key Points
Key points are not available for this paper at this time.
Cite This Study
Albert Schömig (2009) studied this question.